
Sign up to save your podcasts
Or


Episode 3 discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
Gerald Lee, MD: Nothing to disclose
Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
This podcast series is supported by Sanofi Regeneron.
By allergytalk5
5050 ratings
Episode 3 discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
Gerald Lee, MD: Nothing to disclose
Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
This podcast series is supported by Sanofi Regeneron.

91,073 Listeners

43,984 Listeners

32,147 Listeners

38,737 Listeners

496 Listeners

2,442 Listeners

3,331 Listeners

112,586 Listeners

56,435 Listeners

1,153 Listeners

51 Listeners

369 Listeners

185 Listeners

2 Listeners

4 Listeners